Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 157, Issue 2, 2019, Pages 644-652.e9

  Myles, Paul S ^a,b,l   Smith, Julian A ^b,c,l   Kasza, Jessica ^b   Silbert, B ^l   Jayarajah, M ^l   Painter, T ^l   Cooper, D James ^a,b,l   Marasco, Silvana ^a,b,l   McNeil, John ^b,l   Bussieres J S ^l   McGuinness, S ^l   Byrne, K ^l   Chan, M T V ^l   Landoni, G ^l   Wallace, S ^l   Forbes, A ^l   Esmore, Donald ^l   Krum, Henry ^l   Tonkin, A ^l   Buxton, B ^l   Heritier, S ^l   Merry, A ^l   Liew, D ^l   Meehan, A ^l   Galagher, W ^l   Farrington, C ^l   Ditoro, A ^l   Wutzlhofer, L ^l   Story, D ^l   Peyton, P ^l   Baulch, S ^l   Sidiropoulos, S ^l   Potgieter, D ^l   Baker, R A ^l   Pesudovs, B ^l   O'Loughlin J Wells, E ^l   Coutts, P ^l   Bolsin, S ^l   Osborne, C ^l   Ives, K ^l   Hulley, A ^l   Christie Taylor, G ^l   Lang, S ^l   Mackay, H ^l   Cokis, C ^l   March, S ^l   Bannon, P G ^l   Wong, C ^l   Turner, L ^l   Scott, D ^l   Said, S ^l   Corcoran, P ^l   de Prinse, L ^l   Gagne N ^l   Lamy, A ^l   Semelhago, L ^l   Underwood, M ^l   Choi, G S Y ^l   Fung, B ^l   Lembo, R ^l   Monaco, F ^l   Simeone, F ^l   Marianello, D ^l   Alvaro, G ^l   De Vuono, G ^l   van Dijk, D ^l   Dieleman, J ^l   Numan, S ^l   Parke, R ^l   Raudkivi, P ^l   Gilder, E ^l   Dunning, J ^l   Termaat, J ^l   Mans, G ^l   Alderton, J ^l   Waugh, D ^l   Platt, M J ^l   Pai, A ^l   Sevillano, A ^l   Lal, A ^l   Sinclair, C ^l   Kunst, G ^l   Knighton, A ^l   Cubas, G M ^l   Saravanan, P ^l   Millner, R ^l   Vasudevan, V ^l   Patteril, M ^l   Lopez, E ^l   Basu, R ^l   Lu, J ^l   more..

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e DERRIFORD HOSPITAL   (United Kingdom)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g LAVAL UNIVERSITY   (Canada)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

ⁱ WAIKATO HOSPITAL   (New Zealand)

^j CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^k SAN RAFFAELE HOSPITAL   (Italy)

^l NONE

more..

Author keywords

anesthesia; antifibrinolytic; antiplatelet; disability free survival; major adverse cardiac events; outcomes

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; FIBRINOLYTIC AGENT;

AGED; ARTICLE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; CLINICAL OUTCOME; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY RATE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; TREATMENT DURATION; ADVERSE EVENT; BLEEDING; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; DIAGNOSTIC IMAGING; DISABILITY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RISK FACTOR; TIME FACTOR;

ACTIVITIES OF DAILY LIVING; AGED; ANTIFIBRINOLYTIC AGENTS; ASPIRIN; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGRESSION-FREE SURVIVAL; RISK FACTORS; TIME FACTORS; TRANEXAMIC ACID;

EID: 85056745306     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2018.09.113     Document Type: Article

References (35)

1. Henry, D.A., Carless, P.A., Moxey, A.J., O'Connell, D., Stokes, B.J., Fergusson, D.A., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 2011, CD001886.
2. Mangano, D.T., Tudor, I.C., Dietzel, C., The risk associated with aprotinin in cardiac surgery. N Engl J Med 354 (2006), 353–365.
3. Levi, M., Cromheecke, M.E., de Jonge, E., Prins, M.H., de Mol, B.J., Briet, E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354 (1999), 1940–1947.
4. Ponschab, M., Landoni, G., Biondi-Zoccai, G., Bignami, E., Frati, E., Nicolotti, D., et al. Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth 25 (2011), 804–810.
5. Mangano, D.T., Miao, Y., Vuylsteke, A., Tudor, I.C., Juneja, R., Filipescu, D., et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297 (2007), 471–479.
6. Ngaage, D.L., Bland, J.M., Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies. Eur J Cardiothorac Surg 37 (2010), 1375–1383.
7. Mikkola, R., Gunn, J., Heikkinen, J., Wistbacka, J.O., Teittinen, K., Kuttila, K., et al. Use of blood products and risk of stroke after coronary artery bypass surgery. Blood Transfus 10 (2012), 490–501.
8. Ferraris, V.A., Brown, J.R., Despotis, G.J., Hammon, J.W., Reece, T.B., Saha, S.P., et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91 (2011), 944–982.
9. Gaudino, M., Antoniades, C., Benedetto, U., Deb, S., Di Franco, A., Di Giammarco, G., et al. Mechanisms, consequences, and prevention of coronary graft failure. Circulation 136 (2017), 1749–1764.
10. Almassi, G.H., Carr, B.M., Bishawi, M., Shroyer, A.L., Quin, J.A., Hattler, B., et al. Resident versus attending surgeon graft patency and clinical outcomes in on- versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg 150 (2015), 1428–1435 37.e1; discussion 35-7.
11. Myles, P.S., Smith, J.A., Forbes, A., Silbert, B., Jayarajah, M., Painter, T., et al. Tranexamic acid in coronary artery surgery. N Engl J Med 376 (2017), 136–148.
12. Forman, D.E., Arena, R., Boxer, R., Dolansky, M.A., Eng, J.J., Fleg, J.L., et al. Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation 135 (2017), e894–e918.
13. Kalkman, C.J., Kappen, T.H., Patient-centered endpoints for perioperative outcomes research. Anesthesiology 122 (2015), 481–483.
14. Rumsfeld, J.S., Alexander, K.P., Goff, D.C. Jr., Graham, M.M., Ho, P.M., Masoudi, F.A., et al. Cardiovascular health: the importance of measuring patient-reported health status: a scientific statement from the American Heart Association. Circulation 127 (2013), 2233–2249.
15. Newman, A.B., Arnold, A.M., Naydeck, B.L., Fried, L.P., Burke, G.L., Enright, P., et al. “Successful aging”: effect of subclinical cardiovascular disease. Arch Intern Med 163 (2003), 2315–2322.
16. Myles, P., Smith, J., Knight, J., Cooper, D., Silbert, B., McNeil, J., et al. Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. Am Heart J 155 (2008), 224–230.
17. Myles, P.S., Smith, J.A., Forbes, A., Silbert, B., Jayarajah, M., Painter, T., et al. Stopping vs. continuing aspirin before coronary artery surgery. N Engl J Med 374 (2016), 728–737.
18. Dowd, N.P., Karski, J.M., Cheng, D.C., Carroll, J.A., Lin, Y., James, R.L., Butterworth, J., et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 97 (2002), 390–399.
19. Katz, S., Ford, A.B., Moskowitz, R.W., Jackson, B.A., Jaffe, M.W., Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. JAMA 185 (1963), 914–919.
20. Katz, S., Downs, T.D., Cash, H.R., Grotz, R.C., Progress in development of the index of ADL. Gerontologist 10 (1970), 20–30.
21. Williams, M.R., Wellner, R.B., Hartnett, E.A., Thornton, B., Kavarana, M.N., Mahapatra, R., et al. Long-term survival and quality of life in cardiac surgical patients with prolonged intensive care unit length of stay. Ann Thorac Surg 73 (2002), 1472–1478.
22. Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., et al. Third universal definition of myocardial infarction. Circulation 126 (2012), 2020–2035.
23. Shahian, D.M., Heatley, G.J., Westcott, G.A., Relationship of hospital size, case volume, and cost for coronary artery bypass surgery: analysis of 12,774 patients operated on in Massachusetts during fiscal years 1995 and 1996. J Thorac Cardiovasc Surg 122 (2001), 53–64.
24. Koch, C.G., Li, L., Duncan, A.I., Mihaljevic, T., Cosgrove, D.M., Loop, F.D., et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 34 (2006), 1608–1616.
25. LaPar, D.J., Hawkins, R.B., McMurry, T.L., Isbell, J.M., Rich, J.B., Speir, A.M., et al. Preoperative anemia versus blood transfusion: which is the culprit for worse outcomes in cardiac surgery?. J Thorac Cardiovasc Surg 156 (2018), 66–74.e2.
26. Kuduvalli, M., Oo, A.Y., Newall, N., Grayson, A.D., Jackson, M., Desmond, M.J., et al. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg 27 (2005), 592–598.
27. Risch, A., Dorscheid, E., Stein, G., Seyfert, U.T., Grundmann, U., The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass. [in German] Anaesthesist 49 (2000), 279–285.
28. Dentz, M.E., Slaughter, T.F., Mark, J.B., Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid. Anesthesiology 82 (1995), 583–586.
29. Garg, J., Pinnamaneni, S., Aronow, W.S., Ahmad, H., ST elevation myocardial infarction after tranexamic acid: first reported case in the United States. Am J Ther 21 (2014), e221–e224.
30. Stief, T.W., Tranexamic acid triggers thrombin generation. Hemost Lab 2 (2009), 73–82.
31. Draxler, D.F., Medcalf, R.L., The fibrinolytic system-more than fibrinolysis?. Transfus Med Rev 29 (2015), 102–109.
32. World Health Organization. International Classification of Functioning, Disability and Health. 2001, World Health Organization, Geneva, 1–299.
33. Shulman, M.A., Myles, P.S., Chan, M.T., McIlroy, D.R., Wallace, S., Ponsford, J., Measurement of disability-free survival after surgery. Anesthesiology 122 (2015), 524–536.
34. Katz, S., Ford, A.B., Moskowitz, R.W., Jackson, B.A., Jaffe, M.W., Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185 (1963), 914–919.
35. Williams, M.R., Wellner, R.B., Hartnett, E.A., Thornton, B., Kavarana, M.N., Mahapatra, R., et al. Long-term survival and quality of life in cardiac surgical patients with prolonged intensive care unit length of stay. Ann Thorac Surg 73 (2002), 1472–1478.